Substituted pyrrolo[2,3-b]-pyridines and -pyrazines

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8592448
APP PUB NO 20110224191A1
SERIAL NO

13130113

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of Formula I, as shown below and defined herein: (I) pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers mediated at least in part by Ron and/or Met.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OSI PHARMACEUTICALS LLC1 BIOSCIENCE PARK DRIVE FARMINGDALE NY 11735

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Xin Commack, US 816 7998
Jin, Melzhong Dix Hills, US 1 1
Kleinberg, Andrew East Meadow, US 12 51
Li, An-Hu Commack, US 40 353
Mulvihill, Mark J Melville, US 30 121
Steinig, Arno G East Northport, US 19 272
Wang, Jing Syosset, US 1745 13464

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 26, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00